HELEN ANOKHIN-MOGILNAY: Open Payments
NPI 1205139870 · REISTERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 10 payments from 3 companies in 2025. Trend: 2023 $119 · 2024 $451 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $463 |
| Vanda Pharmaceuticals Inc. | 1 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $77 |
Products named: COBENFY, FANAPT, CAPLYTA.
Industry payments across MD — which companies pay providers there.
